Literature DB >> 29751074

Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice.

Tomoko Ohashi1, Masaki Kato2, Akihiro Yamasaki1, Akifumi Kuwano1, Hideo Suzuki1, Motoyuki Kohjima1, Yoshihiro Ogawa3.   

Abstract

Epidemiology shows that the morbidity of nonalcoholic fatty liver disease (NAFLD) is increased in postmenopausal women and chronic high fructose intake induces NAFLD progression. To analyze the effects of high fructose intake on estrogen deficiency, we evaluated liver disease progression using ovariectomized mice fed with a high fat diet (HFD) for 12 weeks. Hepatic steatosis developed in all HFD groups. Fructose intake significantly increased the liver weight and serum alanine aminotransferase, which was not exacerbated by ovariectomy alone. Ovariectomy enhanced the hepatic inflammatory activity shown by tumor necrosis factor α upregulation in the groups with or without fructose intake. Both fructose intake and ovariectomy increased the hepatocytes with ballooning degeneration and hepatic macrophage infiltration and activated hepatic stellate cells. Coexistence of fructose intake and ovariectomy markedly enhanced liver cell destruction, macrophage accumulation, and progression of fibrosis. Liver damage was ameliorated by 17β-estradiol supplementation. These findings suggest that high fructose intake enhanced the progression of NAFLD in ovariectomized female mice.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Estrogen; Fructose; Hepatic steatosis; Menopause; Steatohepatitis

Mesh:

Substances:

Year:  2018        PMID: 29751074     DOI: 10.1016/j.fct.2018.05.006

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  5 in total

Review 1.  The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones.

Authors:  Linlin Xu; Yuan Yuan; Zhaodi Che; Xiaozhi Tan; Bin Wu; Cunchuan Wang; Chengfang Xu; Jia Xiao
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 2.  Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

Authors:  Chanbin Lee; Jieun Kim; Youngmi Jung
Journal:  Cells       Date:  2019-10-15       Impact factor: 6.600

Review 3.  Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling.

Authors:  Sara Della Torre
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

Review 4.  Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors:  Meng Yang; Feng Ma; Min Guan
Journal:  Metabolites       Date:  2021-05-17

5.  Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.

Authors:  Lei Chen; Liangyu Zhang; Wendong Wang; Wei Qiu; Lei Liu; Anhong Ning; Jing Cao; Min Huang; Mintao Zhong
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.